Item 1.01. Entry into a Material Definitive Agreement.
On January 1, 2021, Guardant Health, Inc. (the "Company") entered into an
Amendment #5 to Supply Agreement (the "Amendment") with Illumina, Inc.
("Illumina"), which amends that certain Supply Agreement, dated September 15,
2014, by and between the Company and Illumina, as amended (the "Supply
Agreement"), pursuant to which Illumina provides the Company products and
services used for certain research and clinical activities, including certain
sequencers, equipment and other materials the Company uses in its laboratory
operations. The Amendment provides for, among other things, extending the term
of the Supply Agreement to January 2033. The term of the Supply Agreement will
automatically renew for successive one-year periods after January 2033 unless
the Supply Agreement is terminated earlier in accordance with its terms or
either party provides notice of non-renewal to the other party of not less than
12 months prior to the date such renewal would otherwise take effect. Under the
terms of the Amendment, the Company may also terminate the Supply Agreement for
convenience upon 90 days' prior written notice. The Amendment also updated the
list of specific hardware and consumables, including associated pricing terms
for each, to be provided by Illumina to the Company.
The foregoing description of the Amendment does not purport to be complete and
is qualified in its entirety by reference to the full text of the Amendment, a
copy of which will be filed as an exhibit to the Company's Annual Report on Form
10-K for the fiscal year ended December 31, 2020.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses